This biotechnology company develops genetically engineered animals that lack the capacity to experience physical and mental suffering, while retaining functional nociceptive neurons to prevent self-injury. Their technology aims to replace animals in markets that typically involve chronic suffering, offering a solution for industries reliant on animal products.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods of animal farming often result in significant physical and psychological suffering for livestock. Existing approaches to mitigate this suffering, such as reducetarian/vegan advocacy and cultured meat, face scalability and adoption challenges.
Solution
The Far Out Initiative is developing genetically engineered farm animals with a significantly reduced capacity for experiencing physical and psychological suffering, while maintaining functional nociception to prevent self-injury. This is achieved through germline engineering techniques, specifically gene knockouts, to create animal lines that are profoundly resistant to suffering. These "precision-rred" animals are intended to replace conventionally farmed animals, reducing the overall scope of animal suffering in the meat industry. The company is also exploring human gene therapy to produce adaptive pain insensitivity/asymbolia, aiming to reduce the burden of intense physical and psychological suffering.
Target Audience
The primary target audience includes the meat industry, particularly in markets like the UK and Brazil, seeking to reduce animal suffering, as well as individuals suffering from chronic pain conditions.
Features
- Germline engineering of farm animals to reduce the capacity for suffering.
- Development of "precision-rred" animals using gene-knockout techniques.
- Research into human gene therapy for adaptive pain insensitivity/asymbolia.
- Open access research, collaborative partnerships, and technology transfer.
- Ethical patents to prevent hostile appropriation and ensure accessibility of treatments.
- Continuous monitoring of emerging technologies in tissue engineering and animal-free meat solutions.